DER1.2 Antibody

What is DERL2 and what is its biological function?

DERL2 (Derlin-2) is a functional component of endoplasmic reticulum-associated degradation (ERAD) specifically involved in the degradation of misfolded lumenal glycoproteins, but not misfolded nonglycoproteins. It likely forms a channel that enables retrotranslocation of misfolded glycoproteins into the cytosol where they undergo ubiquitination and subsequent proteasomal degradation. Additionally, DERL2 may mediate interactions between VCP (valosin-containing protein) and misfolded glycoproteins, facilitating their extraction from the ER . DERL2 may also participate in endoplasmic reticulum stress-induced pre-emptive quality control mechanisms that selectively attenuate the translocation of newly synthesized proteins into the ER and redirect them to the cytosol for proteasomal degradation .

How does DERL2 differ functionally from other Derlin family members?

Unlike DERL1 (Derlin-1), DERL2 is not involved in the degradation of MHC class I heavy chains following infection by cytomegaloviruses . While both DERL1 and DERL2 participate in ERAD pathways, they appear to have distinct substrate specificities. DERL2, along with DERL3, shows weak homology to yeast Der1p, a transmembrane protein involved in yeast ERAD . All three Derlins (DERL1, DERL2, and DERL3) are components of mammalian ERAD, but their individual contributions to different ERAD substrates vary .

How are Derlin proteins regulated in response to ER stress?

Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response (UPR) and are targets of the IRE1–XBP1 pathway . Derlin-3 mRNA showed stronger induction than Derlin-2 mRNA in tunicamycin-treated human cells (293T and HeLa cells) . The induction time course of Derlin-3 mRNA was similar to that of Derlin-2 and EDEM mRNA but distinctly slower than BiP mRNA, reflecting differences in DNA binding specificity and activation mechanisms between ATF6 and XBP1 . This regulation pattern suggests that Derlin-2 and Derlin-3, like EDEM, are specific components of the ERAD machinery upregulated during ER stress conditions.

What antibody options are available for detecting DERL2 in experimental systems?

Several commercial antibodies are available for DERL2 detection across different applications and species:

Researchers should select antibodies based on their specific experimental needs, including application requirements and species of interest .

How can researchers validate the specificity of DERL2 antibodies?

Antibody specificity can be verified through immunoblotting using microsomal fractions obtained from wildtype cells compared with DERL2 knockout or knockdown cells. Alternatively, comparison with cells overexpressing DERL2 can provide validation of antibody specificity . For the αDer1 antibody described in the literature, specificity was verified by immunoblotting using microsomal fractions obtained from W303-CD (Δder1) and W303-1C overexpressing DER1 (pRS425 DER1) . This approach of comparing negative and positive controls is essential for ensuring antibody specificity in experimental settings.

What are the optimal conditions for using DERL2 antibodies in Western Blotting?

For Western Blotting applications, the following protocol has been used successfully:

• Extract microsomes from 10 OD600 units of cells

• Lyse in buffer A (50 mM NaH2PO4, pH 5.5, 1% (w/v) SDS, 2% (v/v) Triton X-100, 10 mM EDTA) for 15 minutes at room temperature

• Use antibody at appropriate dilution (e.g., 1:1000 dilution in PBS-T containing 1% (w/v) milk powder for αDer1)

• For deglycosylation experiments prior to Western Blot, add 2 mU of endoglycosidase H (Roche) in buffer B (50 mM NaH2PO4, pH 5.5, 0.02% (w/v) SDS, 10 mM EDTA, 200 μM β-mercaptoethanol) and incubate at 37°C for 1 hour

These conditions can be optimized based on specific experimental requirements and the particular antibody used.

What protocols are recommended for immunohistochemical detection of DERL2?

For immunohistochemical analysis of DERL2:

• Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol

• Use appropriate antibody dilution (e.g., 1/50 dilution for ab185087)

• Proceed with standard immunohistochemistry protocols

• Different tissues may exhibit varying levels of DERL2 expression; for example, human thyroid gland shows high DERL2 expression while skeletal muscle displays low expression

This protocol has been successfully used to detect differential expression of DERL2 across human tissues .

How can researchers study the regulatory mechanisms of DERL2 in response to ER stress?

To study DERL2 regulation during ER stress:

• Induce ER stress using agents such as tunicamycin

• Monitor DERL2 mRNA and protein levels at different time points (the induction time course of Derlin-2 mRNA is similar to EDEM mRNA but slower than BiP mRNA)

• Compare DERL2 regulation in wildtype cells versus cells deficient in specific UPR branches (e.g., IRE1α knockout or XBP1 knockout cells)

• Analyze the promoter region of DERL2 for potential UPR response elements

• Use chromatin immunoprecipitation (ChIP) to determine direct binding of XBP1 to the DERL2 promoter

This approach allows for dissection of the specific UPR pathways regulating DERL2 expression during ER stress conditions .

What approaches can be used to study DERL2 interactions with other ERAD components?

To investigate DERL2 interactions with other ERAD components:

• Co-immunoprecipitation using DERL2 antibodies to pull down interacting partners

• Reciprocal co-IP experiments using antibodies against potential interacting proteins (e.g., VCP, misfolded substrate proteins)

• Proximity labeling techniques such as BioID or APEX to identify proteins in close proximity to DERL2

• Fluorescence resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC) to visualize interactions in living cells

• Crosslinking mass spectrometry to identify direct binding interfaces

Since DERL2 may mediate the interaction between VCP and misfolded glycoproteins , these approaches can provide insights into the molecular mechanisms of DERL2 function in ERAD.

What functional assays can determine the specific contribution of DERL2 to ERAD?

To assess DERL2's specific contribution to ERAD:

• Generate DERL2 knockout or knockdown cell lines

• Introduce well-characterized ERAD substrates (glycosylated and non-glycosylated)

• Monitor substrate degradation kinetics through pulse-chase experiments

• Assess substrate retrotranslocation by monitoring cytosolic appearance of ERAD substrates

• Analyze ER stress responses in DERL2-deficient cells compared to control cells

• Perform rescue experiments with wildtype or mutant DERL2 constructs

These experiments can help distinguish DERL2's role from other Derlin family members and identify its specific substrate preferences .

What controls should be included when using DERL2 antibodies in experimental procedures?

Essential controls for DERL2 antibody experiments include:

• Negative controls:

  • DERL2 knockout or knockdown samples

  • Isotype control antibodies

  • Primary antibody omission control

• Positive controls:

  • Cells overexpressing DERL2

  • Tissues known to express high levels of DERL2 (e.g., thyroid gland)

  • Recombinant DERL2 protein

• Specificity controls:

  • Pre-absorption of antibody with immunizing peptide

  • Comparison of multiple antibodies targeting different epitopes

  • Western blot showing a single band of expected molecular weight

These controls ensure experimental results are specifically attributable to DERL2 detection rather than non-specific interactions .

How can researchers differentiate between DERL1, DERL2, and DERL3 in experimental settings?

To differentiate between the three Derlin family members:

• Use antibodies specifically targeting unique epitopes in each Derlin

• Verify antibody specificity against recombinant proteins of all three Derlins

• Include appropriate knockout/knockdown controls for each Derlin

• Perform comparative expression analysis across different tissues or cell types

• Design PCR primers specific to unique regions of each Derlin for mRNA analysis

• Consider using tagged versions of each Derlin for overexpression studies to avoid antibody cross-reactivity issues

This multi-faceted approach helps ensure accurate distinction between these structurally related family members in experimental settings .